🚀 VC round data is live in beta, check it out!
Mirion Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mirion and similar public comparables like Danieli & C. Officine, Krones, GPGI, Jiangsu Yuyue Medical and more.
Mirion Overview
About Mirion
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Founded
2018
HQ
Employees
3.3K
Website
Financials (LTM)
EV
$6B
Mirion Financials
Mirion reported last 12-month revenue of $989M and EBITDA of $247M.
In the same LTM period, Mirion generated $468M in gross profit, $247M in EBITDA, and $130M in net income.
Revenue (LTM)
Mirion P&L
In the most recent fiscal year, Mirion reported revenue of $925M and EBITDA of $228M.
Mirion expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $989M | XXX | $925M | XXX | XXX | XXX |
| Gross Profit | $468M | XXX | $439M | XXX | XXX | XXX |
| Gross Margin | 47% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | $247M | XXX | $228M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $130M | XXX | $120M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Debt | — | — | $787M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mirion Stock Performance
Mirion has current market cap of $5B, and enterprise value of $6B.
Market Cap Evolution
Mirion's stock price is $19.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $5B | -0.8% | XXX | XXX | XXX | $0.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMirion Valuation Multiples
Mirion trades at 5.8x EV/Revenue multiple, and 23.1x EV/EBITDA.
EV / Revenue (LTM)
Mirion Financial Valuation Multiples
As of April 22, 2026, Mirion has market cap of $5B and EV of $6B.
Equity research analysts estimate Mirion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mirion has a P/E ratio of 37.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 5.8x | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBITDA | 23.1x | XXX | 25.1x | XXX | XXX | XXX |
| EV/EBIT | 52.3x | XXX | 57.3x | XXX | XXX | XXX |
| EV/Gross Profit | 12.2x | XXX | 13.0x | XXX | XXX | XXX |
| P/E | 37.8x | XXX | 40.9x | XXX | XXX | XXX |
| EV/FCF | 41.2x | XXX | 45.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mirion Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mirion Margins & Growth Rates
Mirion's revenue in the last 12 month grew by 17%.
Mirion's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Mirion's rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mirion's rule of X is 83% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mirion Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | 28% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 48% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 83% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mirion Public Comps
See public comps and valuation multiples for other Machinery and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Mirion | XXX | XXX | XXX | XXX | XXX | XXX |
| Danieli & C. Officine | XXX | XXX | XXX | XXX | XXX | XXX |
| Krones | XXX | XXX | XXX | XXX | XXX | XXX |
| GPGI | XXX | XXX | XXX | XXX | XXX | XXX |
| Jiangsu Yuyue Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Interpump Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mirion M&A Activity
Mirion acquired XXX companies to date.
Last acquisition by Mirion was on XXXXXXXX, XXXXX. Mirion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mirion
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMirion Investment Activity
Mirion invested in XXX companies to date.
Mirion made its latest investment on XXXXXXXX, XXXXX. Mirion invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mirion
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mirion
| When was Mirion founded? | Mirion was founded in 2018. |
| Where is Mirion headquartered? | Mirion is headquartered in United States. |
| How many employees does Mirion have? | As of today, Mirion has over 3K employees. |
| Who is the CEO of Mirion? | Mirion's CEO is Thomas D. Logan. |
| Is Mirion publicly listed? | Yes, Mirion is a public company listed on NYSE. |
| What is the stock symbol of Mirion? | Mirion trades under MIR ticker. |
| When did Mirion go public? | Mirion went public in 2020. |
| Who are competitors of Mirion? | Mirion main competitors are Danieli & C. Officine, Krones, GPGI, Jiangsu Yuyue Medical. |
| What is the current market cap of Mirion? | Mirion's current market cap is $5B. |
| What is the current revenue of Mirion? | Mirion's last 12 months revenue is $989M. |
| What is the current revenue growth of Mirion? | Mirion revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Mirion? | Current revenue multiple of Mirion is 5.8x. |
| Is Mirion profitable? | Yes, Mirion is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mirion? | Mirion's last 12 months EBITDA is $247M. |
| What is Mirion's EBITDA margin? | Mirion's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Mirion? | Current EBITDA multiple of Mirion is 23.1x. |
| What is the current FCF of Mirion? | Mirion's last 12 months FCF is $139M. |
| What is Mirion's FCF margin? | Mirion's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mirion? | Current FCF multiple of Mirion is 41.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.